3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase NA
3
Phase 3
3
Phase 1/2
1
Phase 1
1
Status
Completed
119
Terminated
24
Recruiting
13
Unknown
7
Withdrawn
6
Active not recruiting
5
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
36
Leukemia, Myeloid, Acute
27
Colorectal Neoplasms
27
Neoplasms
26
Neoplasm Metastasis
22
Recurrence
21
Multiple Myeloma
20
Advanced Solid Tumors
20
Lymphoma, B-Cell
19
Breast Neoplasms
18
Pancreatic Neoplasms
14
Lung Neoplasms
13
Glioblastoma
13
Carcinoma, Hepatocellular
13
Lymphoma
12
Brain Neoplasms
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Hematologic Neoplasms
11
Glioma
11
Squamous Cell Carcinoma of Head and Neck
10
Ovarian Neoplasms
10
Melanoma
10
Leukemia
10
Advanced Solid Tumor
10
Triple Negative Breast Neoplasms
9
Prostatic Neoplasms
9
Head and Neck Neoplasms
9
Lymphoma, Non-Hodgkin
8
Esophageal Neoplasms
8
Myelodysplastic Syndromes
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Not yet recruiting
×
Carcinoma, Ovarian Epithelial
×
Clear all
NCT06748872
2024-12-27
EPITOME-1015-I
Medigene AG
Phase 1
Not yet recruiting
55 enrolled